When analyzing all the hospitalized patients together, a significant difference in FOXO3A mRNA level was observed between patients without heart failure (NYHA 0) in comparison with the patients with different stages of heart failure (NYHA >0) (p<0.001). This evidence concerns the gene FOXO3 and heart failure.